LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, (Nasdaq: SLN), (“Silence

The average of price targets set by Wall Street analysts indicates a potential upside of 140.1% in S

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (“Silence” or the “Compan

Morgan Stanley analyst Michael Ulz maintains Silence Therapeutics (NASDAQ:SLN) with a Overweight

Silence Therapeutics (NASDAQ: SLN) reported top-line results from its Phase II SANRECO trial of dive

Silence Therapeutics NASDAQ: SLN reported top-line results from its Phase II SANRECO trial of divesi

Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran i

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (“Silence” or the “Compan

Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul

Silence Therapeutics plc (NASDAQ:SLN) stock is trading higher on Monday after the company reported p

Silence Therapeutics reports positive Phase 2 SANRECO trial data for divesiran in polycythemia vera.

BWMN gained 55.1%, HZO rose 45.8%, ABCL gained 35.6%, SLN rose 34.3%, ACHR gained 19.5%, NESR gained

Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (sho

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing nov

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global c

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.09) per share which beat the anal

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, (Nasdaq: SLN), a global

Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (sho

LONDON--(BUSINESS WIRE)---- $SLN #SenseofSilence--Silence Therapeutics plc, (Nasdaq: SLN), a global

Silence Therapeutics shares surge as investors eye key 2026 divesiran data, an advancing RNAi pipeli

Silence Therapeutics (SLN) was a big mover last session on higher-than-average trading volume. The l

I initiate Silence Therapeutics at a speculative Buy, driven by near-term divesiran/SLN124 catalysts

Silence Therapeutics (SLN) saw its shares surge in the last session with trading volume being higher

Silence Therapeutics Plc (NASDAQ:SLN) stock rose Wednesday after Cantor Fitzgerald initiated coverag

Silence Therapeutics ($SLN) stock surges as Cantor predicts key August Phase 2 data will be a major

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Silence Therapeutics (NASDAQ:SLN)

U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls afte

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Silence Therapeutics (NASDAQ:SLN)

Silence Therapeutics Plc (NASDAQ:SLN) shares are up during Friday's session. On Thursday, the compan

Silence Therapeutics says SANRECO data show sustained polycythemia vera benefits as analysts weigh d

New analyses from the Phase 1 SANRECO study demonstrate potential improvements in PV symptoms and qu

Silence Therapeutics (NASDAQ:SLN) reported quarterly losses of $(0.11) per share which beat the anal

Urgent.ly shares surged in pre-market trading after agreement to be acquired by Agero for $5.50 per

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarte

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday.

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

  Tuesday's session saw 286 companies set new 52-week lows.

  On Monday, 147 stocks made new 52-week lows.